LongeVC | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights
LongeVC is a venture capital firm based in Lugano, Switzerland, founded in 2016. The company specializes in supporting early-stage...
LongeVC is a venture capital firm based in Lugano, Switzerland, founded in 2016. The company specializes in supporting early-stage biotech and longevity-focused founders, helping them gain industrial momentum, raise capital, and shape the future of the biotech industry. LongeVC aims to build a broad community of biotech innovators by funding companies in complementary sectors and facilitating collaboration among them.
Website
Headquarters
Paradiso, Lugano
Size
1-10 employees
Industry
Venture Capital and Private Equity Principals
🛍️ LongeVC Product and Pricing News →
👔 LongeVC CEO, Management and Leadership Team →
⚔️ LongeVC Alternatives and Competitors →
💼 LongeVC Hiring and Layoffs →
🤖 LongeVC Developer, Integration and Automation News →
📈 LongeVC Financials, Fundraising and Valuation News →
🛍️ LongeVC Product and Pricing News
- LongeVC's portfolio company HautAI launched SkinGPT, an AI platform for personalized virtual skincare try-ons, using generative AI to simulate product effects and skin changes.
- LongeVC, based in Latvia, is listed as a partner in the RESI Europe 2025 event in Barcelona from April 1-3.
- LongeVC Managing Partner Sergey Jakimov will speak at the Novatore Impact Summit in Riga, focusing on women's economic empowerment and leadership.
- Sergey Jakimov, managing partner at LongeVC, emphasized at the Bioinnovate Symposium that brilliant science alone is insufficient to build a successful biotech business.
- LongeVC's Managing Partner and Head of Investor Relations, Aurora Griffin, will speak at The Livelong Experience event in Palm Beach, Florida, on March 28-29.
- On February 20th, 2025, Sergey Jakimov, Managing Partner at LongeVC, will deliver a keynote speech at the BioInnovate 2025 Symposium in Stevenage.
- Sergey Jakimov, co-founder and partner at LongeVC, emphasizes a pragmatic, disease-driven approach to longevity by investing in treatments for age-related conditions like cancer and neurodegenerative diseases.
- Rubedo Life Sciences, a portfolio company of LongeVC, announced plans for a Phase 1 clinical trial of their GPX4 modulator RLS-1496 targeting aging cells.
👔 LongeVC CEO, Management and Leadership Team
-
Chief Financial Officer
[email protected]
⚔️ LongeVC Alternatives and Competitors
- Aeravti Ventures |
- Black Diamond Ventures
💼 LongeVC Hiring and Layoffs
- Artemy Shumskiy is associated with LongeVC.
- Aurora Griffin has joined LongeVC as Managing Partner and Head of Investor Relations to scale the $250M LongeVC II fund and develop AniVC's $35M fund I.
🤖 LongeVC Developer, Integration and Automation News
- Unnatural Products Inc., a LongeVC portfolio company, is pioneering AI-powered macrocyclic molecule design in collaboration with Merck to enhance drug discovery for complex diseases.
📈 LongeVC Financials, Fundraising and Valuation News
- LongeVC invested in the British startup BioConstructiv, a company specializing in synthetic biology and biotechnology..
- LongeVC has topped up the investment in their portfolio company SiPhox Health to make at-home blood testing more accessible and user-friendly.
- LongeVC has backed SiPhox Health, a portfolio company, in its latest funding round as SiPhox doubled its revenue in 2024 and advanced in product development and R&D.
- LongeVC's portfolio company Melio, led by Mridu Sinha, received a $3.5M grant to develop a platform for rapid identification of bloodstream infections, starting with neonatal sepsis.
- Artem Trotsyuk, operating partner at LongeVC, noted a trend of larger companies acquiring smaller biotechs to access new medicines and technologies.
People also viewed
- Fiedler Capital |
- Yolo Investments |
- Skaala |
- Startup Wise Guys |
- Siena Secondary Fund |
- Thorgate |
- Health Founders |
- Lemonade Stand |
- Trind Ventures |
- Superangel |
- Bridgio |
- BADideas.fund
